Emily L. Olsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emily L. Olsen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Carolyn Brianne Brazell
Department of Biological Sciences, University of Alabama in Huntsville, Huntsville, AL 35899, USA
1 shared publication - Chelsea N. Powers
Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA
1 shared publication - Debra M. Moriarity
Department of Biological Sciences, University of Alabama in Huntsville, Huntsville, AL 35899, USA
1 shared publication - Jessica L. Osier
Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA
1 shared publication - Prabodh Satyal
Aromatic Plant Research Center, 230 N 1200 E, Suite 100, Lehi, UT 84043, USA
1 shared publication - Robert L. McFeeters
Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA
1 shared publication
Latest Publications
- Open Access
Antifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils
There is an urgent and unmet need for new antifungal therapies. Global fungal infection rates continue to rise and fungal infections pose increasing burdens on global healthcare systems. Exacerbating the situation, the available antifungal therapeutic arsenal is limited and development of new antifungals has been slow. Current antifungals are known for unwanted side effects including nephrotoxicity and hepatotoxicity. Thus, the need for new antifungals and new antifungal targets is urgent and growing. A collection of 60 commercially-available essential oils has been screened for antifungal activity against Aspergillus niger, Candida albicans, and Cryptococcus neoformans, as well as for cytotoxic activity against MCF-7 and MDA-MB-231 human breast tumor cell lines; the chemical compositions of the essential oils have been determined by gas chromatography-mass spectrometry (GC-MS). Ten essential oils showed remarkable antifungal and cytotoxic activities: Indian, Australian, and Hawaiian sandalwoods; melissa; lemongrass; cilantro; cassia; cinnamon; patchouli; and vetiver.
Open AccessAntifungal and Cytotoxic Activities of Sixty Commercially-Available Essential Oils
There is an urgent and unmet need for new antifungal therapies. Global fungal infection rates continue to rise and fungal infections pose increasing burdens on global healthcare systems. Exacerbating the situation, the available antifungal therapeutic arsenal is limited and development of new antifungals has been slow. Current antifungals are known for unwanted side effects including nephrotoxicity and hepatotoxicity. Thus, the need for new antifungals and new antifungal targets is urgent and growing. A collection of 60 commercially-available essential oils has been screened for antifungal activity against Aspergillus niger, Candida albicans, and Cryptococcus neoformans, as well as for cytotoxic activity against MCF-7 and MDA-MB-231 human breast tumor cell lines; the chemical compositions of the essential oils have been determined by gas chromatography-mass spectrometry (GC-MS). Ten essential oils showed remarkable antifungal and cytotoxic activities: Indian, Australian, and Hawaiian sandalwoods; melissa; lemongrass; cilantro; cassia; cinnamon; patchouli; and vetiver.